InGel Website
4 known investors
InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous. The company also runs Regenesis, a target discovery platform using single-cell proteomics to identify neuroprotective pathways in the eye.
BiotechDeep TechHealthtech
Founders & leadership
PJ
Patrick JiangCEO & Co-founder
PC
Pierre Colombe DromelChief Technology Officer & Co-founder
DS
Deepti SinghChief Scientific Officer & Co-founder
Investors · 4
Frequently asked questions
- What does InGel Website do?
- InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous. The company also runs Regenesis, a target discovery platform using single-cell proteomics to identify neuroprotective pathways in the eye.
- Who founded InGel Website?
- InGel Website was founded by Patrick Jiang, Pierre Colombe Dromel, Deepti Singh.
- Who are InGel Website's investors?
- InGel Website's investors include MassVentures, The Venture Collective, ZAKA VC, Service Provider Capital.